Fatigue and Associated Factors in an Immune-Mediated Inflammatory Disease Population: A Cross-Sectional Study.
PROMIS
fatigue
immune-mediated inflammatory diseases
inflammatory bowel disease
rheumatoid arthritis
spondyloarthritis
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
27 Apr 2022
27 Apr 2022
Historique:
received:
17
03
2022
revised:
20
04
2022
accepted:
25
04
2022
entrez:
14
5
2022
pubmed:
15
5
2022
medline:
15
5
2022
Statut:
epublish
Résumé
Fatigue is a main symptom of chronic diseases, including immune-mediated inflammatory diseases (IMIDs), such as inflammatory bowel disease (IBD) and inflammatory arthritis (IA); however, the pathophysiological mechanisms are not completely understood. The aim of this study was to assess the prevalence of fatigue and the associated factors in an IMIDs population. A control group, IBD, and IA patients, were enrolled. The PROMIS® fatigue questionnaire was used to evaluate the symptoms. Information on demographics, anthropometrics, disease characteristics, and medications was collected for each participant. A total of 471 subjects (137 with IBD, 103 with IA, and 206 controls) were enrolled. IBD and IA patients reported greater fatigue than controls (p < 0.001, each). In univariate regression, patients with anxiety and depression were more likely to report fatigue (p = 1.40 × 10−9 and p = 3.80 × 10−11, respectively). Males, holding a high school diploma, and being employed were inversely correlated to the domain (p = 1.3 × 10−5; p = 0.003 and p = 0.005, respectively). The use of steroids and disease activity determined increased fatigue (p = 0.014 and p = 0.019; respectively). In the multivariate analysis, anxiety and depression remained associated (p = 0.002 and p = 1.3 × 10−5, respectively). IMIDs patients present increased fatigue compared with healthy subjects. Anxiety and depression are the main associated factors, suggesting a psychological component of the symptom; thus, a holistic management should be established.
Identifiants
pubmed: 35566580
pii: jcm11092455
doi: 10.3390/jcm11092455
pmc: PMC9099976
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Ther Adv Musculoskelet Dis. 2020 Nov 2;12:1759720X20970028
pubmed: 33224281
Inflamm Bowel Dis. 2018 Mar 19;24(4):742-751
pubmed: 29562277
J Rheumatol. 2014 May;41(5):887-96
pubmed: 24692521
Am J Hosp Palliat Care. 2014 Aug;31(5):562-75
pubmed: 23892338
J Crohns Colitis. 2019 Aug 14;13(8):996-1002
pubmed: 30721954
Int J Rheum Dis. 2020 Mar;23(3):302-308
pubmed: 31908153
Med Care. 2007 May;45(5 Suppl 1):S3-S11
pubmed: 17443116
Reumatol Clin (Engl Ed). 2018 Nov - Dec;14(6):360-366
pubmed: 28400099
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S263-86
pubmed: 22588750
Clin Gastroenterol Hepatol. 2014 Aug;12(8):1315-23.e2
pubmed: 24183956
Medicina (Kaunas). 2020 Jan 20;56(1):
pubmed: 31968710
J Psychosom Res. 2016 Aug;87:70-80
pubmed: 27411754
Reumatol Clin (Engl Ed). 2020 Sep - Oct;16(5 Pt 1):339-344
pubmed: 30139690
J Patient Rep Outcomes. 2019 Feb 21;3(1):14
pubmed: 30790155
J Clin Epidemiol. 2016 May;73:89-102
pubmed: 26952842
Health Serv Insights. 2013 Aug 04;6:61-8
pubmed: 25114561
Best Pract Res Clin Rheumatol. 2020 Apr;34(2):101526
pubmed: 32473780
J Psychosom Res. 2017 Oct;101:17-23
pubmed: 28867419
Aliment Pharmacol Ther. 2021 Jan;53(1):138-149
pubmed: 33159475
Arthritis Res Ther. 2020 Aug 26;22(1):198
pubmed: 32847612
Ann Rheum Dis. 2018 Dec;77(12):1736-1741
pubmed: 30237203
Lancet. 1980 Mar 8;1(8167):514
pubmed: 6102236
Semin Arthritis Rheum. 2017 Oct;47(2):175-182
pubmed: 28487138
Clin Rheumatol. 2015 Mar;34(3):497-501
pubmed: 24870035
Nat Rev Gastroenterol Hepatol. 2019 Apr;16(4):247-259
pubmed: 30531816
Nat Rev Rheumatol. 2021 Nov;17(11):651-664
pubmed: 34599320
J Rheumatol Suppl. 2010 May;85:11-26
pubmed: 20436162
BMJ Qual Saf. 2014 Jun;23(6):508-18
pubmed: 24505110
Ann Rheum Dis. 2009 Jun;68(6):777-83
pubmed: 19297344
Phys Ther. 2009 Feb;89(2):125-35
pubmed: 19074618
Rheumatology (Oxford). 2019 Nov 1;58(Suppl 5):v10-v21
pubmed: 31682275
Ann Rheum Dis. 2011 Jan;70(1):47-53
pubmed: 21068095
J Rheumatol. 2020 Aug 1;47(8):1182-1188
pubmed: 31371654
J Clin Epidemiol. 2016 May;73:128-34
pubmed: 26939927
Arthritis Rheum. 2006 Aug;54(8):2665-73
pubmed: 16871531
PLoS One. 2020 Aug 3;15(8):e0237117
pubmed: 32745130
PeerJ. 2021 Oct 27;9:e12100
pubmed: 34760342
J Rheumatol. 2016 Apr;43(4):751-7
pubmed: 26879350
Rheumatology (Oxford). 2013 Dec;52(12):2136-48
pubmed: 24003249
N Engl J Med. 2005 Dec 8;353(23):2462-76
pubmed: 16339095
Expert Rev Clin Immunol. 2018 May;14(5):405-417
pubmed: 29681202
PLoS One. 2019 Jun 28;14(6):e0218831
pubmed: 31251785
Arthritis Rheum. 1995 Jan;38(1):44-8
pubmed: 7818570
Med Sci Sports Exerc. 2016 Nov;48(11):2228-2238
pubmed: 27015386
Arthritis Rheum. 2010 Sep;62(9):2569-81
pubmed: 20872595